Cerebral Salt Wasting Syndrome Management

Diagnosis and Clinical Presentation

Identify clinical signs of hypovolemia in CSW, including orthostatic hypotension, dry mucous membranes, tachycardia, negative fluid balance, and low central venous pressure, in patients with subarachnoid hemorrhage at risk of vasospasm, as recommended by the American Academy of Neurology 1

Classify hyponatremia based on serum sodium levels, with mild (126-135 mEq/L), moderate (120-125 mEq/L), and severe (<120 mEq/L) forms, each with distinct symptoms, as illustrated by the following table:

Volume Status	Clinical Signs	Urine Sodium	Likely Causes
Hypovolemic	Orthostatic hypotension, dry mucous membranes, tachycardia	<20 mEq/L	GI losses, diuretics, CSW, adrenal insufficiency
Euvolemic	No edema, normal vital signs	>20-40 mEq/L	SIADH, hypothyroidism, adrenal insufficiency
Hypervolemic	Edema, ascites, elevated JVP	<20 mEq/L	Heart failure, cirrhosis, renal failure	[2]

Laboratory Findings

Laboratory findings in CSW include hyponatremia (serum sodium <131 mmol/L), elevated urine sodium (>20 mEq/L), elevated urine osmolality, and persistent hypouricemia and increased fractional excretion of urate (even after correction of hyponatremia) 1
Check sodium levels every 2 hours initially, and every 4 hours during initial treatment, as recommended by the Neurosurgery guideline society 1

Treatment

Aggressively resuscitate with isotonic (0.9%) saline for all CSW patients, with a target correction rate not to exceed 8-10 mmol/L in 24 hours to avoid osmotic demyelination syndrome, as recommended by the American Heart Association 3, 1
Use fludrocortisone (0.1-0.4 mg daily) as a first-line pharmacological therapy for CSW, with Class I evidence supporting its use in subarachnoid hemorrhage patients at risk of vasospasm 1
Consider hydrocortisone to prevent natriuresis in subarachnoid hemorrhage patients, with Class I evidence supporting its use 1
Use isotonic solutions such as 0.9% sodium chloride (normal saline) to decrease the risk of worsening hyponatremia, as recommended by the American Academy of Pediatrics and the European Association for the Liver 4, 5
Avoid hypotonic fluids in patients with hyponatremia, as they can worsen the condition 4, 5
Correct chronic hyponatremia at a rate of 4-6 mEq/L per 24-hour period, not exceeding 8 mEq/L per 24 hours, to prevent osmotic demyelination syndrome (ODS), as recommended by the American Association for the Study of Liver Diseases 6

Refractory Cases

Consider albumin as a volume expander during vasospasm phase, though evidence for superiority over crystalloids is limited, in refractory CSW cases 3
Maintain positive salt balance through oral salt supplementation if the patient can tolerate oral intake, in refractory CSW cases 1
Use vaptans, such as conivaptan, to enhance free water excretion without affecting electrolyte excretion in hypervolemic hyponatremia due to heart failure, cirrhosis, and SIADH, as recommended by the American Association for the Study of Liver Diseases 7
Use tolvaptan, a vasopressin receptor antagonist, for short-term treatment (≤30 days) of hyponatremia, with a starting dose of 15 mg once daily, and monitoring for overly rapid correction and hypernatremia, as recommended by the clinical guidelines and the American College of Cardiology and the Clinical and Molecular Hepatology guidelines 5, 8, 9
Infuse albumin for patients with hypoalbuminemia and hyponatremia, as it addresses both conditions, according to the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases 7, 6

Special Considerations

Treat even mild hyponatremia (131-135 mmol/L) in subarachnoid hemorrhage patients, due to the risk of vasospasm, as recommended by the American Academy of Neurology 1
Manage hyperglycemia in diabetic patients using a basal-bolus approach, with an initial dose of 0.3-0.5 units/kg/day divided into basal and bolus components, as recommended by the American Diabetes Association 10
Ensure proper carbohydrate intake and have glucose tablets or equivalent readily available to prevent hypoglycemia, as recommended by the American Diabetes Association 11
Avoid premixed insulin formulations in the hospital setting due to high rates of hypoglycemia, as recommended by the American Diabetes Association 10
Be aware that preterm infants are at higher risk of hyponatremia and hypokalemia due to immature renal tubular function, and sodium depletion is frequent in preterm infants born before 34 weeks gestation, according to the American Academy of Pediatrics 12
Recognize that liver cirrhosis is associated with reduced effective arterial blood volume, and cirrhotic patients with hyponatremia have a poorer prognosis and higher risk of refractory ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome, as reported by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver 13, 7
Understand that untreated hyponatremia can lead to severe complications, such as seizures, coma, and death, especially when serum sodium levels fall below 120 mEq/L, with a mortality rate of 25% compared to 9.3% in patients with sodium >120 mEq/L, as reported by the American Association of Neurological Surgeons 1